TruBridge, Inc. TBRG Patient Care — Product development
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TruBridge, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: TruBridge, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about TruBridge, Inc.'s patient care — product development.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is TruBridge, Inc.'s patient care — product development?
- TruBridge, Inc. (TBRG) reported patient care — product development of $4.26M in Q1 2026.
- How has TruBridge, Inc.'s patient care — product development changed year-over-year?
- TruBridge, Inc.'s patient care — product development decreased by 13.5% year-over-year, from $4.93M to $4.26M.
- What is the long-term trend for TruBridge, Inc.'s patient care — product development?
- Over 3 years (2022 to 2025), TruBridge, Inc.'s patient care — product development has grown at a -9.6% compound annual growth rate (CAGR), from $25.29M to $18.68M.
- What does patient care — product development mean?
- This reflects the investment expenditures dedicated to research, design, and enhancement of the Patient Care segment's software and service offerings. It is a leading indicator of the company's commitment to innovation and its ability to maintain a competitive advantage in the healthcare technology market.